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Abstract
Background: Current methods for identifying patients with pain hypersensitivity are sufficiently
complex to limit their widespread application in clinical settings. We assessed the reliability and
validity of a simple multi-modal vibrotactile stimulus, applied using an electric toothbrush, to
evaluate its potential as a screening tool for central sensitization.
Methods: Fourteen female temporomandibular disorders (TMD) subjects with myofascial pain
(RDC/TMD Ia or Ib) and arthralgia (RDC/TMD IIIa) were compared to 13 pain-free controls of
matched age and gender. Vibrotactile stimulus was performed with an electric toothbrush, applied
with 1 pound pressure for 30 seconds in four locations: over the lateral pole of the
temporomandibular joint, masseter, temporalis, and mid-ventral surface of forearm. Pain intensity
(0–10) was recorded following the stimulus at 0, 15, 30, and 60 seconds. Test-retest reliability was
assessed with measurements from 8 participants, taken 2–12 hours apart. Case versus control
differentiation involved comparison of area under the curve (AUC). A receiver operating
characteristic (ROC) curve was used to determine cutoff AUC scores for maximum sensitivity and
specificity for this multi-modal vibrotactile stimulus.
Results: Test-retest reliability resulted in an ICC of 0.87 for all 4 pooled sites. ROC-determined
AUC cutoff scores resulted in a sensitivity of 57% and specificity of 92% for all 4 pooled sites.
Conclusion: The electric toothbrush stimulus had excellent test-retest reliability. Validity of the
scores was demonstrated with modest sensitivity and good specificity for differentiating TMD pain
patients from controls, which are acceptable properties for a screening test.
Background
Central sensitization, also known as hypersensitivity,
seems to be a common feature of chronic pain conditions
[1]. In patients with painful temporomandibular disor-
ders (TMD), pain is associated with centrally-mediated
sensitization, as measured by several quantitative sensory
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researchers active in this area agree that compared to pain-
free patients, people with chronic TMD pain are more
likely to have alterations in their central processing of
external stimuli within the structures innervated by the
trigeminal nerve, resulting in lower sensory thresholds
[6,7]. This is evidenced by alterations in measures of TMD
pain patients' static pressure-pain threshold [5,8], vibro-
tactile stimulation perception [4], and noxious heat
threshold [9,10], and by the results of dynamic suprath-
reshold tests involving temporal summation, such as the
sub-maximal ischemic tourniquet test [2,3] and the cold-
pressor test [11]. Similar findings have been reported for
other chronic orofacial pain conditions, including chronic
tension-type headaches [12] and neuropathic trigeminal
pain [13-15].
At present there is no standard clinical measure for central
sensitization. Several methods of applying QST for a vari-
ety of stimuli have been reported [16,17], but their appli-
cation in clinical practice has largely been restricted to the
diagnoses of neuropathic pain [18-20]. Development of a
simple, robust test to identify people with hypersensitivity
may be advantageous to healthcare providers. The ability
to readily differentiate people with increased sensitization
could have implications for the diagnostic testing and
classification of pain disorders, and for the prognostica-
tion of chronic pain treatments and patients' post-opera-
tive pain experience [1].
Use of an electric toothbrush to apply a vibrotactile stim-
ulus may produce the desired attributes of not only
dynamic mechanical stimulation, but also thermal and
punctuate mechanical stimulation, with temporal sum-
mation. Such a multi-modal stimulus device has many
practical advantages that increase its likelihood of being
incorporated into clinical practice: The device is low cost,
small and easy to store, simple to operate, and readily
available for purchase. In addition, the stimulation tech-
nique is not time consuming (requires less than two min-
utes per stimulus site), is known to dentists, and is well
tolerated by subjects. For these reasons, an electric tooth-
brush it is a promising instrument for use in a potential
screening test for central sensitization.
One of the first steps in developing a screening tool of this
type is to assess the tool's reliability and groups validity,
i.e., its ability to distinguish a population with known sus-
ceptibility to central sensitization (such as chronic TMD
pain patients) from pain-free controls. Groups validity
testing is an essential part of construct validity assessment
[21-23]. Therefore, the aims of this study were to deter-
mine the test-retest reliability of a vibrotactile stimulus
delivered with an electric toothbrush and to evaluate its
validity in differentiating people with TMD pain from
pain-free controls. This work is an important initial step
towards the development of a screening tool for routine
clinical use.
Methods
The research protocol was reviewed and approved by the
University of Minnesota's Institutional Review Board.
Before providing written consent and HIPAA authoriza-
tion, potential participants were given an explanation of
the study and the opportunity to ask questions about the
protocol.
Subjects
Fliers and newspaper advertisements were placed around
the University of Minnesota campus and in University
clinics to recruit TMD pain cases and pain-free control
subjects, matched on age and gender. Women between 18
and 60 years old and who were not pregnant or lactating
were invited to be screened for study eligibility.
To be included as cases, women had to have self-reported
pain in both the masseter muscle and temporomandibu-
lar joint (TMJ) over the last month, with a pain intensity
in the range of 3 to 8 on a 10-point scale (with 0 represent-
ing "no pain" and 10 representing the "worst pain imagi-
nable"). In addition, they had to meet the diagnostic
criteria for myofascial pain and arthralgia (RDC/TMD Ia
or Ib and IIIa) [24], as rendered by a calibrated clinical
examiner. Pain had to be present at the time of testing and
at least 50% of the time, which is consistent with the Inter-
national Classification of Headache Disorders [25]. Pain
also had to be present for at least 6 months prior to the
sensory testing, but no longer than 10 years; this criterion
was to ensure that the pain was chronic in nature, while
excluding subjects with intractable pain, since they are
most likely to have irreversible changes in the central pain
pathways. Subjects' pain could be either unilateral or
bilateral. If bilateral, vibrotactile stimulation was per-
formed on the most painful side. Signs or symptoms of
TMJ disc displacement were allowed, as long as noises that
occurred with jaw function did not specifically elicit an
increase in pain.
Pain-free controls were defined as women with no history
of bodily pain within the past 3 months, no history of jaw
pain, and a normal, pain-free mandibular range of
motion (e.g., 40 mm vertical inter-incisal opening cor-
rected for anterior vertical overlap).
For both controls and cases, we excluded anyone with a
major systemic illness related to altered pain sensitivity, or
with fibromyalgia or other widespread bodily pains; a his-
tory of TMJ surgery or inter-articular steroid injection; a
history of traumatic injuries to the orofacial region; cur-
rently receiving active TMD treatment; or taking analgesicsPage 2 of 8
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ity.
Psychophysical Testing
Vibrotactile stimulus with an electric toothbrush was per-
formed by one trained person (AH), a dentist who was
unaware of subject's pain status. The stimulus was applied
during the 5th through 10th days of the subject's menstrual
cycle, if a cycle was present, since research suggests that
pain sensitivity in women can vary across different stages
of the menstrual cycle [11]. The stimulus was delivered by
using an electric toothbrush (Braun Oral-B) with the fol-
lowing properties: brush head of 1 cm in diameter, with
22 tufts of bristles and approximately 50 polished bristles
per tuft. The head of the toothbrush moved in a rotational
manner, 10 degrees in each direction, at a frequency of 5
Hz. The brush head was applied perpendicular to the skin
with 1 pound pressure for 30 seconds, or for the maxi-
mum time tolerated when less than 30 seconds. Prior to
and immediately following application of the stimulus,
the examiner calibrated the pressure applied by using a
postal scale. The vibrotactile stimulus was applied in four
locations (Figure 1). Three were ipsilateral to the self-
report of greatest pain: over the lateral pole of the tempo-
romandibular joint, mid-masseter, and anterior tempora-
lis. One site was contralateral to self-report of greatest pain
(mid ventral forearm) to serve as a control location (one
that is not innervated by the trigeminal nerve), as previ-
ously used by others [2]. The contralateral ventral forearm
site was included to capture wide-spread hypersensitivity,
if present.
Resultant pain intensity was measured on a 0–10 numeric
rating scale following the vibrotactile stimulus at 0, 15,
30, and 60 seconds. For each individual, the pain intensity
figures were plotted against time and connected with a
line. The area under the line was calculated and used as
the measure of vibrotactile stimulation. Therefore, the
area represented the amount of pain experienced by the
individual over time, measured in pain intensity-seconds
(Figure 2). The maximum area for a single test site was 10,
multiplied by 60 seconds, or 600 intensity-seconds. With
all four test sites pooled together, the maximum potential
area was 2400 intensity-seconds.
This method of psychophysical testing differs from the
diagnostic palpation component of the RDC/TMD in four
ways. First, the vibrotactile stimulus includes psychophys-
ical modalities other than palpation, such as vibration
and brushings of the skin. Second, less pressure is used (1
pound versus the 2 pounds used for muscle palpation.
Third, fewer numbers of sites are used (4 as opposed to
20), with one of the sites being outside the innervation of
the trigeminal nerve. Fourth, the outcome measure is not
a static dichotomous "yes/no" response or a range of "no
pain/mild/moderate/severe," but rather a dynamic meas-
ure of pain intensity over time, following a standard stim-
ulus duration; this is thought to be the best method to
assess wind-up and represents changes in the central mod-
ulation of pain [26].
Reliability Assessment
Test-retest reliability was assessed in a convenience subset
of subjects (N = 8) for whom the stimuli were adminis-
tered twice, over a time interval of 2 to 12 hours. The skin
at the site of stimulus application was marked with a felt
pen for ease of identification upon reapplication for test-
retest reliability. Intraclass correlation coefficients (ICC)
and their 95% confidence intervals were calculated based
on a one-way repeated measures ANOVA [27]. Limits of
agreement were computed around the mean of the differ-
ences including a 95% confidence interval for the mean
[28]. The goodness of the reliability coefficients was eval-
uated according to published guidelines [29].
Validity Assessment
Differentiation of TMD pain subjects from controls is a
component of construct validity, known as groups validity
Example of vibrotactile stimuli being applied at all four sites: a) temporalis muscle, b) lateral pole of temporomandibular joint (TMJ), c) mass t r muscle, and d) mid-ventral contr lat-er l for armFigure 1
Example of vibrotactile stimuli being applied at all 
four sites: a) temporalis muscle, b) lateral pole of 
temporomandibular joint (TMJ), c) masseter muscle, 
and d) mid-ventral contralateral forearm.
a b
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sus pain-free controls involved a receiver operating char-
acteristic (ROC) curve. At each point of the vibrotactile
stimulus scale, a two by two table was constructed that
tabulated predicted and true TMD case and control status.
Sensitivity and 1-specificity were derived from each table.
A ROC curve plotted sensitivity versus 1-specificity over
the entire range of the vibrotactile stimulus scale. The
maximum sum of sensitivity and specificity was deter-
mined as the point of the vibrotactile stimulus measure
for best differentiation of TMD cases from controls. Con-
fidence intervals for the area under the (ROC) curve
(AUC) were determined for each test site and pooled tests
to determine the goodness of differentiating cases from
controls. An area of 1 represents perfect discrimination, an
area of 0.5 represents no discrimination at all, and an area
of 0 represents perfect discrimination with an inverse rela-
tionship. Goodness of AUC was interpreted according to
guidelines http://gim.unmc.edu/dxtests/ROC3.htm.
Statistical Methods
All analyses were performed using the statistical software
package STATA (Stata Statistical Software: Release 9. Col-
lege Station, TX: StataCorp LP). Differences between cases'
and controls' characteristics (age, ethnicity, marital status,
level of education, mean household income, presence of
any headache in last year, and presence of migraine head-
aches) were tested using a t-test for continuous data and
chi-squared tests for dichotomous variables. Results were
considered statistically significant if p < 0.05.
Results
Subjects
All TMD pain cases and pain-free control subjects were
evaluated over a period of four months at the University
of Minnesota Oral Health Clinical Research Center,
within the School of Dentistry. Nineteen people with
TMD pain were screened to obtain the 14 cases; most were
recruited from clinical settings at our institution. Fifteen
pain-free controls, matched on age and gender, were
screened to obtain the 13 controls. All of those screened
who fit the enrollment criteria agreed to participate in the
study, and all enrolled subjects completed the research
protocol.
Cases and controls were of similar age, marital status, and
socioeconomic status (Table 1). A higher proportion of
white subjects were observed in the TMD pain group than
in the control group. Reports of headache pain in the last
year and a diagnosis of migraines were more frequent in
TMD pain subjects than in the control group, but these
differences did not reach statistical significance, likely due
to low power.
Mean pain rating for the masseter muscle site at each time point (0, 15, 30, 60 sec) for pain-free controls and TMD casesFigure 2
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of 4.6 (95% CI 4.0–5.3) over the last month and 3.9 (95%
CI 3.0–4.9) on the day of evaluation, prior to vibrotactile
stimulation. On average, the time since onset of their
TMD pain was 109 months (95% CI 74–143).
All subjects tolerated the vibrotactile stimulus, and no one
withdrew from the study. A complete set of data points
were obtained (no missing values).
Assessment of Reliability
Except for one reliability coefficient, all coefficients
exceeded the threshold of 0.75 (Table 2), which is consid-
ered "excellent" reliability [30]. The most variable stimu-
lus location was the temporalis site, which had an ICC of
0.57. By applying accepted guidelines, this level of relia-
bility can be considered "moderate." The highest reliabil-
ity coefficient observed was for the masseter site, 0.98,
with almost perfect reliability (95% CI 0.96 to 1.00).
Assessment of Validity
Three variables (temporalis, three TMD sites combined,
and all four sites combined) reached "fair" discrimination
of cases from controls. The lower limits of their 95% con-
fidence intervals exceeded the 0.5 value (Table 3), provid-
ing evidence for groups validity. The remaining three
variables (masseter, TMJ, and forearm) did not reach the
threshold of 0.7 for "fair" discrimination. These had AUCs
of 0.66 to 0.69, and their lower confidence limits of 0.45
to 0.49 did not reach the 0.5 threshold for statistical sig-
nificance.
Discussion
Interpretation and Relevance of Findings
Our study suggests that the application of a vibrotactile
stimulus using an electric toothbrush is a reliable and
valid approach to measuring central pain sensitization in
the orofacial region of subjects with TMD pain for screen-
ing purposes. This implies that the application of such a
stimulus may be able to distinguish people who have
increased central sensitization associated with the presen-
tation of trigeminally-mediated TMD pain from those
who do not have such pain.
QST as Assessment for Central Sensitivity
A positive pain response to an individual QST modality is
suggestive of sensitization (in the absence of signs or
symptoms that explain obvious peripheral reasons for






Mean (SE) or N (%)
Age, years 36 (3.1) 36 (3.3) 0.95
Ethnicity, white 13 (93%) 8 (62%) 0.05
Marital status, married 5 (36%) 5 (38%) 0.88
Education, > high school 13 (93%) 13 (100%) 0.96
Household income, >$40,000/year 7 (50%) 8 (62%) 0.55
Headache presence in last year, yes 12 (86%) 7 (54%) 0.07
Migraine diagnosis, yes 6 (43%) 2 (15%) 0.12
Table 2: Test-retest Reliability
Site ICC1 (95% CI*) Test-retest differences in intensity seconds
Mean (95% CI*) Limits of agreement
Masseter 0.98 (0.96 – 1.00) 2 (-1 to 5) -5 to 9
Temporalis 0.57 (0.05 – 1.00) -19 (-52 to 14) -91 to 52
TMJ 0.86 (0.67 – 1.00) -5 (-21 to 12) -44 to 35
3 TMD sites pooled 0.84 (0.64 – 1.00) -13 (-55 to 28) -112 to 86
Forearm 0.79 (0.51 – 1.00) -5 (-14 to 4) -26 to 16
All 4 sites pooled 0.87 (0.70 – 1.00) -24 (-65 to 16) -122 to 73
1 ICC – intraclass correlation coefficients, * CI – confidence interval
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ject response variability makes it difficult to derive clini-
cally meaningful conclusions from individual QST
measurements [30]. To improve upon this, researchers
have developed a battery of individual QST measure-
ments, but the series of tests is time consuming, requires
specialized equipment, and needs specific expertise to
interpret the results [30-33]. These features inhibit the
implementation of individual, modality-specific QST in
typical clinical practice settings, which prompted us to
investigate other testing options.
Suprathreshold tests and multi-modal tests, such as the
thermal and ischemic tolerance tests, are thought to be
robust at detecting alterations in central sensitization. The
problem is that the suprathreshold tests reported in the
literature are time consuming and by nature produce a
strong algesic response [2,3,11] – unfavorable characteris-
tics for use in a clinical practice setting. For these reasons,
we explored the stimulus properties produced by an elec-
tric toothbrush.
To our knowledge, no previous studies have investigated
a multi-modal vibrotactile stimulus such as the one tested
in our study in people with TMD pain. One study assessed
the use of an electric toothbrush as a stimulus in people
with burning mouth syndrome [34]. A statistically signif-
icant difference in pain intensity was found between pain
and non-pain controls immediately following stimula-
tion, and at 1 and 2 minutes after stimulation. This was
similar to the observed response to heat and cold pain
stimuli, which were also assessed; however, the magni-
tude of the group differences was largest for the vibrotac-
tile stimuli compared to heat and cold pain at the 1 and 2
minute time points [34]. This finding is in line with the
assumption that multi-modal stimuli produce a more
robust response. This study did not report sensitivity, spe-
cificity, or test-retest data.
Several studies have investigated the individual compo-
nents likely present within the multi-modal vibrotactile
stimulus used in our study. It has been shown that the
vibration detection threshold is impaired in TMD pain
patients, such that larger amplitudes are needed to elicit a
response [4]. Temporal summation of heat pain [3] and
mild noxious mechanical stimuli [4] results in increased
report of pain compared to pain-free controls. These
reports suggest that TMD pain causes an overall increased
sensitivity to varying types of superficial stimuli applied to
the overlying facial skin [5]. It also demonstrates a lack of
knowledge regarding the ability of various QST to dis-
criminate TMD pain subjects from pain-free controls,
since results from individual QST modalities are known to
vary significantly [35].
At present, the most robust estimates of the sensitivity and
specificity for diagnosing TMD pain have been derived
within the RDC/TMD validation study, which has only
been published in abstract form [36].
For the diagnosis of myofascial pain, the use of experi-
enced gold-standard examiners produced a sensitivity
ranging from 0.78 to 0.84 and a specificity ranging from
0.97 to 0.99 [36]. In the same study, blinded test examin-
ers following the RDC/TMD protocol yielded a sensitivity
ranging from 0.66 to 0.81 and a specificity of 0.90 to 0.92.
This is similar to our values of 0.57 for sensitivity and 0.92
for specificity, which were derived from 5 minutes by
applying a standard QST stimulus. It is desirable for a
screening test to have a high specificity, thus protecting
against false positives, even if this is at the expense of sen-
sitivity [23]. Given that this test was applied in a popula-
tion without long-term chronic pain or wide-spread pain,
the application of a multi-modal stimulus using an elec-
tric tooth brush faired well against the gold-standard diag-
nostic test.
Limitations of Findings
We investigated subjects with TMD pain because it is rela-
tively common [37], diagnostically well defined
[24,36,38], and known to be associated with increased
central sensitization [2,3,5,6]. Since TMD pain is trigemi-
Table 3: Differentiating TMD Cases from Controls
Site AUC* (95% CI) Best cut-off point (max. no of subjects correctly classified)
Cut-off point Correctly classified Sensitivity Specificity
[intensity sec] [%]
Masseter 0.69 (0.49 – 0.89) 60 74 57 92
Temporalis 0.77 (0.58 – 0.95) 30 78 71 85
TMJ 0.66 (0.45 – 0.87) 128 67 43 92
3 TMD sites combined 0.77 (0.69 – 0.95) 140 74 57 92
Forearm 0.66 (0.46 – 0.87) 8 70 64 77
All 4 sites combined 0.79 (0.62 – 0.97) 218 74 57 92
* AUC – Area under curvePage 6 of 8
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patients often experience greater difficulty with routine
oral care such as dental cleanings, root canal procedures,
and tooth extractions [39,40]. Additionally, like all people
with chronic pain conditions, patients with TMD pain are
known to have more co-morbid psychological disorders
[41] than pain-free persons, and those with elevated
somatization tend to over-report physical symptoms [42].
At present it is not clear whether the changes observed
with QST are the result of mechanisms associated with the
chronic pain itself or co-morbid psychological disorders,
as altered QST has been shown in depressed people with-
out pain [43].
Conclusion
In conclusion, this study showed that the screening tech-
nique under investigation – measurement of the pain
response at over 60 seconds after application of vibrotac-
tile stimulation with an electric toothbrush – has good
specificity, modest sensitivity, and excellent test-retest reli-
ability. The stimulus was accepted and tolerated by all
subjects and has properties that are conducive for its use
as a screening test in both clinical and population
research. Further research is needed to better delineate the
characteristics, limitations, and discriminative properties
of this vibrotactile stimulus, as well as its potential clinical
uses in prognostication and evaluation of treatment out-
comes.
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